{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:34:36Z","timestamp":1792611276115,"version":"4.5.0"},"reference-count":100,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:00:00Z","timestamp":1517356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Drugs"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s40272-018-0283-3","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T13:45:19Z","timestamp":1517406319000},"page":"223-233","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Rotavirus Vaccines: Effectiveness, Safety, and Future Directions"],"prefix":"10.1007","volume":"20","author":[{"given":"Eleanor","family":"Burnett","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh","family":"Parashar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Tate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,31]]},"reference":[{"key":"283_CR1","unstructured":"Causes of child mortality, by country, 2000\u20132010. 29 August 2017]; Available from: http:\/\/www.who.int\/gho\/child_health\/mortality\/mortality_causes_text\/en\/."},{"key":"283_CR2","doi-asserted-by":"crossref","unstructured":"Tate JE, Burton AH, Boschi-Pinto C, Parashar UD, World Health Organization-Coordinated Global Rotavirus Surveillance N. Global, regional, and national estimates of rotavirus mortality in children\u00a0<\u00a05 years of age, 2000\u20132013. Clin Infect Dis. 2016;62(Suppl 2):S96\u2013S105.","DOI":"10.1093\/cid\/civ1013"},{"key":"283_CR3","doi-asserted-by":"crossref","unstructured":"Ansari SA, Springthorpe VS, Sattar SA. Survival and vehicular spread of human rotaviruses: possible relation to seasonality of outbreaks. Rev Infect Dis. 1991;13(3):448\u201361.","DOI":"10.1093\/clinids\/13.3.448"},{"issue":"2","key":"283_CR4","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1056\/NEJM198307143090203","volume":"309","author":"RF Bishop","year":"1983","unstructured":"Bishop RF, Barnes GL, Cipriani E, Lund JS. Clinical immunity after neonatal rotavirus infection. A prospective longitudinal study in young children. N Engl J Med. 1983;309(2):72\u20136.","journal-title":"N Engl J Med"},{"issue":"5","key":"283_CR5","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1086\/342294","volume":"186","author":"TK Fischer","year":"2002","unstructured":"Fischer TK, Valentiner-Branth P, Steinsland H, Perch M, Santos G, Aaby P, et al. Protective immunity after natural rotavirus infection: a community cohort study of newborn children in Guinea-Bissau, west Africa. J Infect Dis. 2002;186(5):593\u20137.","journal-title":"J Infect Dis"},{"issue":"4","key":"283_CR6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJMoa1006261","volume":"365","author":"BP Gladstone","year":"2011","unstructured":"Gladstone BP, Ramani S, Mukhopadhya I, Muliyil J, Sarkar R, Rehman AM, et al. Protective effect of natural rotavirus infection in an Indian birth cohort. N Engl J Med. 2011;365(4):337\u201346.","journal-title":"N Engl J Med"},{"issue":"14","key":"283_CR7","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1056\/NEJM199610033351404","volume":"335","author":"FR Velazquez","year":"1996","unstructured":"Velazquez FR, Matson DO, Calva JJ, Guerrero L, Morrow AL, Carter-Campbell S, et al. Rotavirus infection in infants as protection against subsequent infections. N Engl J Med. 1996;335(14):1022\u20138.","journal-title":"N Engl J Med"},{"issue":"3","key":"283_CR8","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1093\/infdis\/144.3.218","volume":"144","author":"M Gurwith","year":"1981","unstructured":"Gurwith M, Wenman W, Hinde D, Feltham S, Greenberg H. A prospective study of rotavirus infection in infants and young children. J Infect Dis. 1981;144(3):218\u201324.","journal-title":"J Infect Dis"},{"issue":"4","key":"283_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/infdis\/145.4.483","volume":"145","author":"RE Black","year":"1982","unstructured":"Black RE, Greenberg HB, Kapikian AZ, Brown KH, Becker S. Acquisition of serum antibody to Norwalk Virus and rotavirus and relation to diarrhea in a longitudinal study of young children in rural Bangladesh. J Infect Dis. 1982;145(4):483\u20139.","journal-title":"J Infect Dis"},{"issue":"5","key":"283_CR10","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3201\/eid0905.020562","volume":"9","author":"UD Parashar","year":"2003","unstructured":"Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9(5):565\u201372.","journal-title":"Emerg Infect Dis"},{"issue":"16","key":"283_CR11","first-page":"514","volume":"60","author":"Centers for Disease C, Prevention","year":"2011","unstructured":"Centers for Disease C, Prevention. Rotavirus surveillance\u2014worldwide, 2009. MMWR Morb Mortal Wkly Rep. 2011;60(16):514\u20136.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"283_CR12","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1128\/mr.53.4.410-449.1989","volume":"53","author":"MK Estes","year":"1989","unstructured":"Estes MK, Cohen J. Rotavirus gene structure and function. Microbiol Rev. 1989;53(4):410\u201349.","journal-title":"Microbiol Rev"},{"issue":"6","key":"283_CR13","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1053\/j.gastro.2009.02.076","volume":"136","author":"HB Greenberg","year":"2009","unstructured":"Greenberg HB, Estes MK. Rotaviruses: from pathogenesis to vaccination. Gastroenterology. 2009;136(6):1939\u201351.","journal-title":"Gastroenterology"},{"issue":"1","key":"283_CR14","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/rmv.448","volume":"15","author":"N Santos","year":"2005","unstructured":"Santos N, Hoshino Y. Global distribution of rotavirus serotypes\/genotypes and its implication for the development and implementation of an effective rotavirus vaccine. Rev Med Virol. 2005;15(1):29\u201356.","journal-title":"Rev Med Virol"},{"issue":"10","key":"283_CR15","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2217\/fmb.09.96","volume":"4","author":"J Matthijnssens","year":"2009","unstructured":"Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Banyai K, Rahman M, et al. Rotavirus disease and vaccination: impact on genotype diversity. Future Microbiol. 2009;4(10):1303\u201316.","journal-title":"Future Microbiol."},{"issue":"2","key":"283_CR16","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/infdis\/168.2.282","volume":"168","author":"MK Bhan","year":"1993","unstructured":"Bhan MK, Lew JF, Sazawal S, Das BK, Gentsch JR, Glass RI. Protection conferred by neonatal rotavirus infection against subsequent rotavirus diarrhea. J Infect Dis. 1993;168(2):282\u20137.","journal-title":"J Infect Dis"},{"issue":"1","key":"283_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa052434","volume":"354","author":"GM Ruiz-Palacios","year":"2006","unstructured":"Ruiz-Palacios GM, Perez-Schael I, Velazquez FR, Abate H, Breuer T, Clemens SC, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"283_CR18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa052664","volume":"354","author":"T Vesikari","year":"2006","unstructured":"Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23\u201333.","journal-title":"N Engl J Med"},{"key":"283_CR19","unstructured":"Introduction of Rotavirus Vaccines: information for policy makers, programme managers, and health workers. World Health Organization; 2013. http:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/vpd\/surveillance_type\/sentinel\/rotavirus_intro_guidance_who_july31_2013.pdf."},{"issue":"41","key":"283_CR20","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.15585\/mmwr.mm6541a3","volume":"65","author":"A Loharikar","year":"2016","unstructured":"Loharikar A, Dumolard L, Chu S, Hyde T, Goodman T, Mantel C. Status of new vaccine introduction\u2014worldwide, September 2016. MMWR Morb Mortal Wkly Rep. 2016;65(41):1136\u201340.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"283_CR21","unstructured":"Vaccine in national immunization programme update. 2017 29 August 2017]; Available from: http:\/\/www.who.int\/immunization\/monitoring_surveillance\/data\/en\/."},{"issue":"9935","key":"283_CR22","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/S0140-6736(13)62630-6","volume":"383","author":"N Bhandari","year":"2014","unstructured":"Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9935):2136\u201343.","journal-title":"Lancet"},{"issue":"12","key":"283_CR23","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMoa1609462","volume":"376","author":"S Isanaka","year":"2017","unstructured":"Isanaka S, Guindo O, Langendorf C, Matar Seck A, Plikaytis BD, Sayinzoga-Makombe N, et al. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger. N Engl J Med. 2017;376(12):1121\u201330.","journal-title":"N Engl J Med"},{"key":"283_CR24","doi-asserted-by":"publisher","unstructured":"Kirkwood CD, Ma LF, Carey ME, Steele AD. The rotavirus vaccine development pipeline. Vaccine. 2017. https:\/\/doi.org\/10.1016\/j.vaccine.2017.03.076","DOI":"10.1016\/j.vaccine.2017.03.076"},{"issue":"12","key":"283_CR25","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1097\/INF.0000000000000086","volume":"32","author":"T Vesikari","year":"2013","unstructured":"Vesikari T, Uhari M, Renko M, Hemming M, Salminen M, Torcel-Pagnon L, et al. Impact and effectiveness of RotaTeq(R) vaccine based on 3\u00a0years of surveillance following introduction of a rotavirus immunization program in Finland. Pediatr Infect Dis J. 2013;32(12):1365\u201373.","journal-title":"Pediatr Infect Dis J."},{"issue":"5","key":"283_CR26","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/infdis\/jir390","volume":"204","author":"C Yen","year":"2011","unstructured":"Yen C, Figueroa JR, Uribe ES, Carmen-Hernandez LD, Tate JE, Parashar UD, et al. Monovalent rotavirus vaccine provides protection against an emerging fully heterotypic G9P[4] rotavirus strain in Mexico. J Infect Dis. 2011;204(5):783\u20136.","journal-title":"J Infect Dis"},{"issue":"1","key":"283_CR27","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1542\/peds.2012-3804","volume":"132","author":"MM Cortese","year":"2013","unstructured":"Cortese MM, Immergluck LC, Held M, Jain S, Chan T, Grizas AP, et al. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics. 2013;132(1):e25\u201333.","journal-title":"Pediatrics"},{"issue":"2","key":"283_CR28","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1542\/peds.2009-1246","volume":"125","author":"FT Wang","year":"2010","unstructured":"Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD. Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States. Pediatrics. 2010;125(2):e208\u201313.","journal-title":"Pediatrics"},{"issue":"9741","key":"283_CR29","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","volume":"376","author":"GE Armah","year":"2010","unstructured":"Armah GE, Sow SO, Breiman RF, Dallas MJ, Tapia MD, Feikin DR, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606\u201314.","journal-title":"Lancet"},{"issue":"4","key":"283_CR30","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJMoa0904797","volume":"362","author":"SA Madhi","year":"2010","unstructured":"Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362(4):289\u201398.","journal-title":"N Engl J Med"},{"issue":"9741","key":"283_CR31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","volume":"376","author":"K Zaman","year":"2010","unstructured":"Zaman K, Dang DA, Victor JC, Shin S, Yunus M, Dallas MJ, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):615\u201323.","journal-title":"Lancet"},{"issue":"45","key":"283_CR32","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","volume":"35","author":"PS Kulkarni","year":"2017","unstructured":"Kulkarni PS, Desai S, Tewari T, Kawade A, Goyal N, Garg BS, et al. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants. Vaccine. 2017;35(45):6228\u201337.","journal-title":"Vaccine."},{"key":"283_CR33","unstructured":"UNICEF Supply Catalogue\u2014Rotavirus. In: Division S, editor. UNICEF; 2017. https:\/\/www.unicef.org\/supply\/files\/Rotavaccine.pdf. Accessed 25 Jan 2018."},{"key":"283_CR34","unstructured":"Detailed Product Profiles\u2014Rotavirus. [7 November 2017]; Available from: http:\/\/www.gavi.org\/library\/gavi-documents\/supply-procurement\/detailed-product-profiles\/."},{"issue":"32 Suppl 1","key":"283_CR35","doi-asserted-by":"publisher","first-page":"A124","DOI":"10.1016\/j.vaccine.2014.03.003","volume":"11","author":"JK Zade","year":"2014","unstructured":"Zade JK, Kulkarni PS, Desai SA, Sabale RN, Naik SP, Dhere RM. Bovine rotavirus pentavalent vaccine development in India. Vaccine. 2014;11(32 Suppl 1):A124\u20138.","journal-title":"Vaccine."},{"key":"283_CR36","unstructured":"Monitoring vaccine wastage at country level: guidelines for program managers. In: Immunization V, and Biologicals, editor. World Health Organization; 2005. http:\/\/apps.who.int\/iris\/bitstream\/10665\/68463\/1\/WHO_VB_03.18.Rev.1_eng.pdf.  Accessed 25 Jan 2018."},{"key":"283_CR37","doi-asserted-by":"crossref","unstructured":"Wallace AS, Willis F, Nwaze E, Dieng B, Sipilanyambe N, Daniels D, et al. Vaccine wastage in Nigeria: an assessment of wastage rates and related vaccinator knowledge, attitudes and practices. Vaccine. 2017;35(48):6751\u20138.","DOI":"10.1016\/j.vaccine.2017.09.082"},{"key":"283_CR38","doi-asserted-by":"crossref","unstructured":"Jonesteller CL, Burnett E, Yen C, Tate JE, Parashar UD. Effectiveness of rotavirus vaccination: a systematic review of the first decade of global post-licensure data, 2006\u20132016. Clin Infect Dis. 2017;65(5):840\u201350.","DOI":"10.1093\/cid\/cix369"},{"issue":"3","key":"283_CR39","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3109\/00365549009027046","volume":"22","author":"T Ruuska","year":"1990","unstructured":"Ruuska T, Vesikari T. Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis. 1990;22(3):259\u201367.","journal-title":"Scand J Infect Dis"},{"issue":"1","key":"283_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.virusres.2012.04.001","volume":"167","author":"H Wang","year":"2012","unstructured":"Wang H, Moon S, Wang Y, Jiang B. Multiple virus infection alters rotavirus replication and expression of cytokines and Toll-like receptors in intestinal epithelial cells. Virus Res. 2012;167(1):48\u201355.","journal-title":"Virus Res"},{"issue":"27","key":"283_CR41","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1016\/j.vaccine.2016.04.080","volume":"34","author":"M Taniuchi","year":"2016","unstructured":"Taniuchi M, Platts-Mills JA, Begum S, Uddin MJ, Sobuz SU, Liu J, et al. Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants. Vaccine. 2016;34(27):3068\u201375.","journal-title":"Vaccine."},{"issue":"200 Suppl 1","key":"283_CR42","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1086\/605035","volume":"01","author":"M Patel","year":"2009","unstructured":"Patel M, Shane AL, Parashar UD, Jiang B, Gentsch JR, Glass RI. Oral rotavirus vaccines: how well will they work where they are needed most? J Infect Dis. 2009;01(200 Suppl 1):S39\u201348.","journal-title":"J Infect Dis"},{"issue":"6","key":"283_CR43","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.vaccine.2013.12.017","volume":"32","author":"MB Appaiahgari","year":"2014","unstructured":"Appaiahgari MB, Glass R, Singh S, Taneja S, Rongsen-Chandola T, Bhandari N, et al. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants. Vaccine. 2014;32(6):651\u20136.","journal-title":"Vaccine."},{"issue":"10","key":"283_CR44","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1086\/340103","volume":"34","author":"B Jiang","year":"2002","unstructured":"Jiang B, Gentsch JR, Glass RI. The role of serum antibodies in the protection against rotavirus disease: an overview. Clin Infect Dis. 2002;34(10):1351\u201361.","journal-title":"Clin Infect Dis"},{"issue":"30 Suppl 1","key":"283_CR45","doi-asserted-by":"publisher","first-page":"A30","DOI":"10.1016\/j.vaccine.2011.11.093","volume":"27","author":"M Patel","year":"2012","unstructured":"Patel M, Steele AD, Parashar UD. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines. Vaccine. 2012;27(30 Suppl 1):A30\u20135.","journal-title":"Vaccine."},{"issue":"2","key":"283_CR46","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1093\/cid\/civ807","volume":"62","author":"DM Emperador","year":"2016","unstructured":"Emperador DM, Velasquez DE, Estivariz CF, Lopman B, Jiang B, Parashar U, et al. Interference of monovalent, bivalent, and trivalent oral poliovirus vaccines on monovalent rotavirus vaccine immunogenicity in rural Bangladesh. Clin Infect Dis. 2016;62(2):150\u20136.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"283_CR47","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1097\/INF.0000000000001253","volume":"35","author":"S Ramani","year":"2016","unstructured":"Ramani S, Mamani N, Villena R, Bandyopadhyay AS, Gast C, Sato A, et al. Rotavirus serum IgA immune response in children receiving rotarix coadministered with bOPV or IPV. Pediatr Infect Dis J. 2016;35(10):1137\u20139.","journal-title":"Pediatr Infect Dis J."},{"key":"283_CR48","doi-asserted-by":"crossref","unstructured":"Harris V, Ali A, Fuentes S, Korpela K, Kazi M, Tate J, et al. Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan. Gut Microbes. 2017;11:1\u20139.","DOI":"10.1080\/19490976.2017.1376162"},{"issue":"1","key":"283_CR49","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/infdis\/jiw518","volume":"215","author":"VC Harris","year":"2017","unstructured":"Harris VC, Armah G, Fuentes S, Korpela KE, Parashar U, Victor JC, et al. Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural Ghana. J Infect Dis. 2017;215(1):34\u201341.","journal-title":"J Infect Dis"},{"issue":"9","key":"283_CR50","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S1473-3099(14)70832-1","volume":"14","author":"E Leshem","year":"2014","unstructured":"Leshem E, Lopman B, Glass R, Gentsch J, Banyai K, Parashar U, et al. Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis. Lancet Infect Dis. 2014;14(9):847\u201356.","journal-title":"Lancet Infect Dis."},{"issue":"11","key":"283_CR51","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1093\/cid\/ciu633","volume":"59","author":"J Nordgren","year":"2014","unstructured":"Nordgren J, Sharma S, Bucardo F, Nasir W, Gunaydin G, Ouermi D, et al. Both Lewis and secretor status mediate susceptibility to rotavirus infections in a rotavirus genotype-dependent manner. Clin Infect Dis. 2014;59(11):1567\u201373.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"283_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/cid\/civ873","volume":"62","author":"A Kambhampati","year":"2016","unstructured":"Kambhampati A, Payne DC, Costantini V, Lopman BA. Host genetic susceptibility to enteric viruses: a systematic review and meta analysis. Clin Infect Dis. 2016;62(1):11\u20138.","journal-title":"Clin Infect Dis"},{"issue":"62 Suppl 2","key":"283_CR53","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1093\/cid\/civ1207","volume":"01","author":"PA Gastanaduy","year":"2016","unstructured":"Gastanaduy PA, Steenhoff AP, Mokomane M, Esona MD, Bowen MD, Jibril H, et al. Effectiveness of monovalent rotavirus vaccine after programmatic implementation in botswana: a multisite prospective case-control study. Clin Infect Dis. 2016;01(62 Suppl 2):S161\u20137.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"283_CR54","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/cid\/ciw346","volume":"63","author":"ER Colgate","year":"2016","unstructured":"Colgate ER, Haque R, Dickson DM, Carmolli MP, Mychaleckyj JC, Nayak U, et al. Delayed dosing of oral rotavirus vaccine demonstrates decreased risk of rotavirus gastroenteritis associated with serum zinc: a randomized controlled trial. Clin Infect Dis. 2016;63(5):634\u201341.","journal-title":"Clin Infect Dis"},{"issue":"62 Suppl 2","key":"283_CR55","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1093\/cid\/ciw014","volume":"1","author":"G Armah","year":"2016","unstructured":"Armah G, Pringle K, Enweronu-Laryea CC, Ansong D, Mwenda JM, Diamenu SK, et al. Impact and effectiveness of monovalent rotavirus vaccine against severe rotavirus diarrhea in Ghana. Clin Infect Dis. 2016;1(62 Suppl 2):S200\u20137.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"283_CR56","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1093\/infdis\/jiu335","volume":"210","author":"SA Ali","year":"2014","unstructured":"Ali SA, Kazi AM, Cortese MM, Fleming JA, Parashar UD, Jiang B, et al. Impact of different dosing schedules on the immunogenicity of the human rotavirus vaccine in infants in Pakistan: a randomized trial. J Infect Dis. 2014;210(11):1772\u20139.","journal-title":"J Infect Dis"},{"issue":"6","key":"283_CR57","doi-asserted-by":"publisher","first-page":"e0127622","DOI":"10.1371\/journal.pone.0127622","volume":"10","author":"A Ali","year":"2015","unstructured":"Ali A, Kazi AM, Cortese MM, Fleming JA, Moon S, Parashar UD, et al. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine\u2014a randomized trial. PLoS One. 2015;10(6):e0127622.","journal-title":"PLoS One"},{"issue":"4","key":"283_CR58","doi-asserted-by":"publisher","first-page":"238","DOI":"10.2471\/BLT.13.128066","volume":"92","author":"MJ Groome","year":"2014","unstructured":"Groome MJ, Moon SS, Velasquez D, Jones S, Koen A, van Niekerk N, et al. Effect of breastfeeding on immunogenicity of oral live-attenuated human rotavirus vaccine: a randomized trial in HIV-uninfected infants in Soweto, South Africa. Bull World Health Organ. 2014;92(4):238\u201345.","journal-title":"Bull World Health Organ."},{"issue":"10","key":"283_CR59","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/INF.0b013e3181e232ea","volume":"29","author":"SS Moon","year":"2010","unstructured":"Moon SS, Wang Y, Shane AL, Nguyen T, Ray P, Dennehy P, et al. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J. 2010;29(10):919\u201323.","journal-title":"Pediatr Infect Dis J."},{"issue":"15","key":"283_CR60","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/1745-6215-15-256","volume":"28","author":"T Rongsen-Chandola","year":"2014","unstructured":"Rongsen-Chandola T, Winje BA, Goyal N, Rathore SS, Mahesh M, Ranjan R, et al. Compliance of mothers following recommendations to breastfeed or withhold breast milk during rotavirus vaccination in North India: a randomized clinical trial. Trials. 2014;28(15):256.","journal-title":"Trials."},{"issue":"10","key":"283_CR61","doi-asserted-by":"publisher","first-page":"699","DOI":"10.2217\/fvl-2016-0082","volume":"11","author":"E Burnett","year":"2016","unstructured":"Burnett E, Yen C, Tate JE, Parashar UD. Rotavirus vaccines: current global impact and future perspectives. Future Virol. 2016;11(10):699\u2013708.","journal-title":"Future Virol."},{"issue":"1","key":"283_CR62","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/jpids\/piv076","volume":"6","author":"S Becker-Dreps","year":"2017","unstructured":"Becker-Dreps S, Choi WS, Stamper L, Vilchez S, Velasquez DE, Moon SS, et al. Innate immune factors in mothers\u2019 breast milk and their lack of association with rotavirus vaccine immunogenicity in Nicaraguan infants. J Pediatr Infect Dis Soc. 2017;6(1):87\u201390.","journal-title":"J Pediatr Infect Dis Soc."},{"key":"283_CR63","doi-asserted-by":"crossref","unstructured":"Lazarus RP, John J, Shanmugasundaram E, Rajan AK, Thiagarajan S, Giri S, et al. The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: a randomized, factorial design, placebo-controlled study among Indian infants. Vaccine. 2018;36(2):273\u20139.","DOI":"10.1016\/j.vaccine.2017.07.116"},{"issue":"62 Suppl 2","key":"283_CR64","doi-asserted-by":"publisher","first-page":"S188","DOI":"10.1093\/cid\/civ1204","volume":"01","author":"MJ Groome","year":"2016","unstructured":"Groome MJ, Zell ER, Solomon F, Nzenze S, Parashar UD, Izu A, et al. Temporal association of rotavirus vaccine introduction and reduction in all-cause childhood diarrheal hospitalizations in South Africa. Clin Infect Dis. 2016;01(62 Suppl 2):S188\u201395.","journal-title":"Clin Infect Dis"},{"issue":"30 Suppl 1","key":"283_CR65","doi-asserted-by":"publisher","first-page":"A44","DOI":"10.1016\/j.vaccine.2011.08.080","volume":"27","author":"SA Madhi","year":"2012","unstructured":"Madhi SA, Kirsten M, Louw C, Bos P, Aspinall S, Bouckenooghe A, et al. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. Vaccine. 2012;27(30 Suppl 1):A44\u201351.","journal-title":"Vaccine."},{"issue":"11","key":"283_CR66","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00431-010-1242-3","volume":"169","author":"T Vesikari","year":"2010","unstructured":"Vesikari T, Karvonen A, Ferrante SA, Ciarlet M. Efficacy of the pentavalent rotavirus vaccine, RotaTeq(R), in Finnish infants up to 3\u00a0years of age: the Finnish Extension Study. Eur J Pediatr. 2010;169(11):1379\u201386.","journal-title":"Eur J Pediatr"},{"issue":"30 Suppl 1","key":"283_CR67","doi-asserted-by":"publisher","first-page":"A36","DOI":"10.1016\/j.vaccine.2011.09.120","volume":"27","author":"NA Cunliffe","year":"2012","unstructured":"Cunliffe NA, Witte D, Ngwira BM, Todd S, Bostock NJ, Turner AM, et al. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial. Vaccine. 2012;27(30 Suppl 1):A36\u201343.","journal-title":"Vaccine."},{"issue":"11","key":"283_CR68","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/infdis\/jiw024","volume":"213","author":"K Zaman","year":"2016","unstructured":"Zaman K, Fleming JA, Victor JC, Yunus M, Bari TI, Azim T, et al. Noninterference of rotavirus vaccine with measles-rubella vaccine at 9 months of age and improvements in antirotavirus immunity: a randomized trial. J Infect Dis. 2016;213(11):1686\u201393.","journal-title":"J Infect Dis"},{"key":"283_CR69","unstructured":"PATH. Immune response to rotavirus vaccine after a supplemental dose given at 9 months of age with local EPI vaccines in Mali. 18 August 2015 ed. ClinicalTrials.gov; 2015. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02286895."},{"issue":"4","key":"283_CR70","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1056\/NEJMoa0905211","volume":"362","author":"V Richardson","year":"2010","unstructured":"Richardson V, Hernandez-Pichardo J, Quintanar-Solares M, Esparza-Aguilar M, Johnson B, Gomez-Altamirano CM, et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med. 2010;362(4):299\u2013305.","journal-title":"N Engl J Med"},{"key":"283_CR71","doi-asserted-by":"crossref","unstructured":"do Carmo GM, Yen C, Cortes J, Siqueira AA, de Oliveira WK, Cortez-Escalante JJ, et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med. 2011;8(4):e1001024.","DOI":"10.1371\/journal.pmed.1001024"},{"issue":"11","key":"283_CR72","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1093\/infdis\/jix186","volume":"215","author":"E Burnett","year":"2017","unstructured":"Burnett E, Jonesteller CL, Tate JE, Yen C, Parashar UD. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017;215(11):1666\u201372.","journal-title":"J Infect Dis"},{"key":"283_CR73","doi-asserted-by":"publisher","unstructured":"Leshem E, Tate JE, Steiner CA, Curns AT, Lopman BA, Parashar UD. National estimates of reductions in acute gastroenteritis\u2013related hospitalizations and associated costs in US children after implementation of rotavirus vaccines. J Pediatr Infect Dis Soc. 2017:pix057. https:\/\/doi.org\/10.1093\/jpids\/pix057","DOI":"10.1093\/jpids\/pix057"},{"key":"283_CR74","first-page":"1","volume":"04","author":"MP Shah","year":"2017","unstructured":"Shah MP, Tate JE, Mwenda JM, Steele AD, Parashar UD. Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa. Expert Rev Vaccines. 2017;04:1\u20139.","journal-title":"Expert Rev Vaccines."},{"key":"283_CR75","unstructured":"Rotavirus vaccines. WHO position paper\u2014January 2013. Wkly Epidemiol Rec. 2013;88(5):49\u201364."},{"issue":"6","key":"283_CR76","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1542\/peds.110.6.e67","volume":"110","author":"G Peter","year":"2002","unstructured":"Peter G, Myers MG, National Vaccine Advisory C, National Vaccine Program O. Intussusception, rotavirus, and oral vaccines: summary of a workshop. Pediatrics. 2002;110(6):e67.","journal-title":"Pediatrics"},{"key":"283_CR77","unstructured":"Parashar UD, Alexander JP, Glass RI, Advisory Committee on Immunization Practices CfDC, Prevention. Prevention of rotavirus gastroenteritis among infants and children. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55(RR-12):1\u201313."},{"issue":"8","key":"283_CR78","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1056\/NEJM200102223440804","volume":"344","author":"TV Murphy","year":"2001","unstructured":"Murphy TV, Gargiullo PM, Massoudi MS, Nelson DB, Jumaan AO, Okoro CA, et al. Intussusception among infants given an oral rotavirus vaccine. N Engl J Med. 2001;344(8):564\u201372.","journal-title":"N Engl J Med"},{"issue":"11","key":"283_CR79","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1586\/erv.09.106","volume":"8","author":"MM Patel","year":"2009","unstructured":"Patel MM, Haber P, Baggs J, Zuber P, Bines JE, Parashar UD. Intussusception and rotavirus vaccination: a review of the available evidence. Expert Rev Vaccines. 2009;8(11):1555\u201364.","journal-title":"Expert Rev Vaccines."},{"issue":"1","key":"283_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/INF.0b013e3181af8605","volume":"29","author":"EA Belongia","year":"2010","unstructured":"Belongia EA, Irving SA, Shui IM, Kulldorff M, Lewis E, Yin R, et al. Real-time surveillance to assess risk of intussusception and other adverse events after pentavalent, bovine-derived rotavirus vaccine. Pediatr Infect Dis J. 2010;29(1):1\u20135.","journal-title":"Pediatr Infect Dis J."},{"issue":"6","key":"283_CR81","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/jama.2012.97","volume":"307","author":"IM Shui","year":"2012","unstructured":"Shui IM, Baggs J, Patel M, Parashar UD, Rett M, Belongia EA, et al. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants. JAMA. 2012;307(6):598\u2013604.","journal-title":"JAMA"},{"issue":"6","key":"283_CR82","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa1311738","volume":"370","author":"ES Weintraub","year":"2014","unstructured":"Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370(6):513\u20139.","journal-title":"N Engl J Med"},{"issue":"10","key":"283_CR83","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/cid\/cit520","volume":"57","author":"JB Carlin","year":"2013","unstructured":"Carlin JB, Macartney KK, Lee KJ, Quinn HE, Buttery J, Lopert R, et al. Intussusception risk and disease prevention associated with rotavirus vaccines in Australia\u2019s National Immunization Program. Clin Infect Dis. 2013;57(10):1427\u201334.","journal-title":"Clin Infect Dis"},{"issue":"24","key":"283_CR84","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","volume":"364","author":"MM Patel","year":"2011","unstructured":"Patel MM, Lopez-Collada VR, Bulhoes MM, De Oliveira LH, Bautista Marquez A, Flannery B, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364(24):2283\u201392.","journal-title":"N Engl J Med"},{"issue":"6","key":"283_CR85","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1056\/NEJMoa1303164","volume":"370","author":"WK Yih","year":"2014","unstructured":"Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, et al. Intussusception risk after rotavirus vaccination in U.S. infants. N Engl J Med. 2014;370(6):503\u201312.","journal-title":"N Engl J Med"},{"issue":"32","key":"283_CR86","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1016\/j.vaccine.2016.04.050","volume":"34","author":"J Stowe","year":"2016","unstructured":"Stowe J, Andrews N, Ladhani S, Miller E. The risk of intussusception following monovalent rotavirus vaccination in England: a self-controlled case-series evaluation. Vaccine. 2016;34(32):3684\u20139.","journal-title":"Vaccine."},{"issue":"7","key":"283_CR87","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1097\/INF.0000000000000715","volume":"34","author":"D Rosillon","year":"2015","unstructured":"Rosillon D, Buyse H, Friedland LR, Ng SP, Velazquez FR, Breuer T. Risk of intussusception after rotavirus vaccination: meta-analysis of postlicensure studies. Pediatr Infect Dis J. 2015;34(7):763\u20138.","journal-title":"Pediatr Infect Dis J."},{"issue":"3","key":"283_CR88","doi-asserted-by":"publisher","first-page":"631","DOI":"10.3349\/ymj.2017.58.3.631","volume":"58","author":"KY Kim","year":"2017","unstructured":"Kim KY, Kim DS. Relationship between pentavalent rotavirus vaccine and intussusception: a retrospective study at a single center in Korea. Yonsei Med J. 2017;58(3):631\u20136.","journal-title":"Yonsei Med J"},{"issue":"22","key":"283_CR89","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1016\/j.vaccine.2009.03.016","volume":"27","author":"MM Patel","year":"2009","unstructured":"Patel MM, Clark AD, Glass RI, Greenberg H, Tate J, Santosham M, et al. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception. Vaccine. 2009;27(22):2916\u201322.","journal-title":"Vaccine."},{"issue":"12","key":"283_CR90","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1097\/INF.0000000000001327","volume":"35","author":"D Wu","year":"2016","unstructured":"Wu D, Yen C, Yin ZD, Li YX, Liu N, Liu YM, et al. The public health burden of rotavirus disease in children younger than five years and considerations for rotavirus vaccine introduction in China. Pediatr Infect Dis J. 2016;35(12):e392\u20138.","journal-title":"Pediatr Infect Dis J."},{"issue":"7","key":"283_CR91","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.vaccine.2012.12.020","volume":"31","author":"EJ Luna","year":"2013","unstructured":"Luna EJ, Frazatti-Gallina NM, Timenetsky MC, Cardoso MR, Veras MA, Miraglia JL, et al. A phase I clinical trial of a new 5-valent rotavirus vaccine. Vaccine. 2013;31(7):1100\u20135.","journal-title":"Vaccine."},{"issue":"12","key":"283_CR92","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/S1473-3099(15)00227-3","volume":"15","author":"JE Bines","year":"2015","unstructured":"Bines JE, Danchin M, Jackson P, Handley A, Watts E, Lee KJ, et al. Safety and immunogenicity of RV3-BB human neonatal rotavirus vaccine administered at birth or in infancy: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2015;15(12):1389\u201397.","journal-title":"Lancet Infect Dis."},{"issue":"9","key":"283_CR93","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1080\/21645515.2016.1179412","volume":"12","author":"AD Steele","year":"2016","unstructured":"Steele AD, Madhi SA, Cunliffe NA, Vesikari T, Phua KB, Lim FS, et al. Incidence of rotavirus gastroenteritis by age in African, Asian and European children: Relevance for timing of rotavirus vaccination. Hum Vaccin Immunother. 2016;12(9):2406\u201312.","journal-title":"Hum Vaccin Immunother."},{"issue":"6","key":"283_CR94","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1542\/peds.106.6.1413","volume":"106","author":"UD Parashar","year":"2000","unstructured":"Parashar UD, Holman RC, Cummings KC, Staggs NW, Curns AT, Zimmerman CM, et al. Trends in intussusception-associated hospitalizations and deaths among US infants. Pediatrics. 2000;106(6):1413\u201321.","journal-title":"Pediatrics"},{"issue":"3","key":"283_CR95","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/infdis\/jit174","volume":"208","author":"GE Armah","year":"2013","unstructured":"Armah GE, Kapikian AZ, Vesikari T, Cunliffe N, Jacobson RM, Burlington DB, et al. Efficacy, immunogenicity, and safety of two doses of a tetravalent rotavirus vaccine RRV-TV in Ghana with the first dose administered during the neonatal period. J Infect Dis. 2013;208(3):423\u201331.","journal-title":"J Infect Dis"},{"issue":"6","key":"283_CR96","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.4161\/hv.28857","volume":"10","author":"C Yen","year":"2014","unstructured":"Yen C, Tate JE, Hyde TB, Cortese MM, Lopman BA, Jiang B, et al. Rotavirus vaccines: current status and future considerations. Hum Vaccin Immunother. 2014;10(6):1436\u201348.","journal-title":"Hum Vaccin Immunother."},{"issue":"8","key":"283_CR97","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S1473-3099(17)30242-6","volume":"17","author":"MJ Groome","year":"2017","unstructured":"Groome MJ, Koen A, Fix A, Page N, Jose L, Madhi SA, et al. Safety and immunogenicity of a parenteral P2-VP8-P[8] subunit rotavirus vaccine in toddlers and infants in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis. 2017;17(8):843\u201353.","journal-title":"Lancet Infect Dis."},{"issue":"8","key":"283_CR98","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nm.2182","volume":"16","author":"SP Sullivan","year":"2010","unstructured":"Sullivan SP, Koutsonanos DG, Del Pilar Martin M, Lee JW, Zarnitsyn V, Choi SO, et al. Dissolving polymer microneedle patches for influenza vaccination. Nat Med. 2010;16(8):915\u201320.","journal-title":"Nat Med"},{"issue":"34","key":"283_CR99","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1016\/j.vaccine.2012.09.062","volume":"31","author":"C Edens","year":"2013","unstructured":"Edens C, Collins ML, Ayers J, Rota PA, Prausnitz MR. Measles vaccination using a microneedle patch. Vaccine. 2013;31(34):3403\u20139.","journal-title":"Vaccine."},{"issue":"34","key":"283_CR100","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1016\/j.vaccine.2012.11.027","volume":"31","author":"S Moon","year":"2013","unstructured":"Moon S, Wang Y, Edens C, Gentsch JR, Prausnitz MR, Jiang B. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine. 2013;31(34):3396\u2013402.","journal-title":"Vaccine."}],"container-title":["Pediatric Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40272-018-0283-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40272-018-0283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:06:59Z","timestamp":1744715219000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40272-018-0283-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,31]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["283"],"URL":"https:\/\/doi.org\/10.1007\/s40272-018-0283-3","relation":{},"ISSN":["1174-5878","1179-2019"],"issn-type":[{"value":"1174-5878","type":"print"},{"value":"1179-2019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,31]]},"assertion":[{"value":"31 January 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}